Pfizer is Buying a Cardiovascular Biopharma Company for $6.7Bn
(thenationalpulse.com)
You're viewing a single comment thread. View all comments, or full comment thread.
Comments (1)
sorted by:
They know what's coming and want to make as much $ as possible while controlling the market and the messaging.